HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Low-level mosaicism in tuberous sclerosis complex in four unrelated patients: Comparison of clinical characteristics and diagnostic pathways.

Abstract
Tuberous sclerosis complex (TSC) is an autosomal dominant neurocutaneous syndrome caused by either TSC1 or TSC2 gene mutations. About 15% of TSC patients remain without genetic diagnosis by conventional analysis despite clinical evidence. It is important to identify somatic mosaics, as therapeutic options are now available in patients with TSC1 or TSC2 mutations. Here, we describe the clinical and genetic characteristics of four male TSC patients with low-level mosaicism. Patients presented at ages between 9 months and 32 years. Clinical manifestations varied considerably and included brain lesions in all four patients, cardiac rhabdomyomas in two young patients, skin involvement in two patients, and retinal hamartomas and renal angiomyolipomas in three patients. One patient presented with epileptic seizures and psychomotor delay. Low levels of mosaicism for TSC1 or TSC2 mutation were found in different tissue samples employing next generation sequencing and multiple ligation-dependent probe amplification. The five disease-associated variants, including one second-hit mutation, include three truncating mutations and one deletion in TSC2, and one truncating mutation in TSC1. Sanger sequencing, allele-specific oligonucleotide PCR (ASO-PCR), and droplet digital PCR were used to confirm and quantify the disclosed mutations. Genetic identification of low-level mosaicism for TSC remains challenging but is important for optimal surveillance and management.
AuthorsHéctor Hugo Manzanilla-Romero, Denisa Weis, Simon Schnaiter, Sabine Rudnik-Schöneborn
JournalAmerican journal of medical genetics. Part A (Am J Med Genet A) Vol. 185 Issue 12 Pg. 3851-3858 (12 2021) ISSN: 1552-4833 [Electronic] United States
PMID34328706 (Publication Type: Case Reports)
Copyright© 2021 The Authors. American Journal of Medical Genetics Part A published by Wiley Periodicals LLC.
Chemical References
  • TSC1 protein, human
  • TSC2 protein, human
  • Tuberous Sclerosis Complex 1 Protein
  • Tuberous Sclerosis Complex 2 Protein
Topics
  • Adolescent
  • Adult
  • Angiomyolipoma (complications, genetics, pathology)
  • Child
  • Child, Preschool
  • Genetic Predisposition to Disease
  • Hamartoma (complications, genetics, pathology)
  • High-Throughput Nucleotide Sequencing
  • Humans
  • Infant
  • Male
  • Mosaicism
  • Mutation (genetics)
  • Retina (pathology)
  • Tuberous Sclerosis (diagnosis, diagnostic imaging, genetics, pathology)
  • Tuberous Sclerosis Complex 1 Protein (genetics)
  • Tuberous Sclerosis Complex 2 Protein (genetics)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: